X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1726) 1726
Publication (125) 125
Book Chapter (21) 21
Book Review (19) 19
Newsletter (3) 3
Magazine Article (2) 2
Dissertation (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1444) 1444
sezary-syndrome (900) 900
male (781) 781
female (697) 697
middle aged (656) 656
index medicus (630) 630
aged (583) 583
dermatology (575) 575
mycosis-fungoides (538) 538
mycosis fungoides (497) 497
adult (480) 480
t-cell lymphoma (468) 468
skin neoplasms - pathology (442) 442
oncology (392) 392
skin neoplasms - drug therapy (376) 376
sezary syndrome (374) 374
skin neoplasms - therapy (308) 308
sezary syndrome - drug therapy (298) 298
mycosis fungoides - pathology (288) 288
hematology (283) 283
aged, 80 and over (279) 279
cutaneous t-cell lymphoma (273) 273
treatment outcome (273) 273
sezary syndrome - pathology (271) 271
sézary syndrome (244) 244
therapy (243) 243
prognosis (234) 234
lymphoma, t-cell, cutaneous - pathology (232) 232
lymphoma, t-cell, cutaneous - drug therapy (226) 226
t cells (223) 223
mycosis fungoides - drug therapy (211) 211
sezary syndrome - therapy (206) 206
neoplasm staging (204) 204
cancer (198) 198
mycosis fungoides - therapy (193) 193
lymphomas (191) 191
antineoplastic agents - therapeutic use (188) 188
non-hodgkin's lymphomas (170) 170
lymphoma, t-cell, cutaneous - therapy (167) 167
classification (162) 162
skin (161) 161
skin neoplasms - diagnosis (158) 158
lymphoma (156) 156
retrospective studies (156) 156
expression (154) 154
care and treatment (146) 146
diagnosis (135) 135
skin neoplasms - immunology (133) 133
mycoses (131) 131
chemotherapy (129) 129
international-society (128) 128
combined modality therapy (124) 124
lymphocytes (119) 119
follow-up studies (116) 116
photopheresis (112) 112
sezary syndrome - immunology (112) 112
disease progression (111) 111
prognostic-factors (111) 111
photochemotherapy (110) 110
sezary syndrome - diagnosis (110) 110
skin - pathology (106) 106
european-organization (105) 105
skin neoplasms - mortality (103) 103
antineoplastic combined chemotherapy protocols - therapeutic use (101) 101
mycosis fungoides - diagnosis (101) 101
remission induction (100) 100
leukemia (92) 92
phase-ii trial (92) 92
dermatology & venereal diseases (90) 90
extracorporeal photochemotherapy (87) 87
immunohistochemistry (87) 87
skin neoplasms - genetics (86) 86
survival (82) 82
survival rate (82) 82
research (81) 81
animals (80) 80
disease (80) 80
adolescent (79) 79
biopsy (79) 79
mycosis fungoides/sezary-syndrome (79) 79
phase-ii (78) 78
puva therapy (78) 78
cutaneous-lymphomas (77) 77
lymphoma, t-cell, cutaneous - immunology (77) 77
task-force (77) 77
young adult (77) 77
trial (75) 75
bexarotene (74) 74
cell biology (73) 73
lymphoma, t-cell, cutaneous - diagnosis (73) 73
mycosis fungoides - immunology (72) 72
mycosis fungoides - mortality (71) 71
analysis (70) 70
phototherapy (70) 70
apoptosis (69) 69
diagnosis, differential (69) 69
united-states (68) 68
sezary syndrome - genetics (67) 67
transplantation (67) 67
lymphocytes t (66) 66
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1631) 1631
German (40) 40
French (38) 38
Spanish (11) 11
Polish (10) 10
Japanese (8) 8
Russian (6) 6
Czech (2) 2
Hungarian (2) 2
Italian (2) 2
Portuguese (2) 2
Chinese (1) 1
Croatian (1) 1
Serbian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Cancer, ISSN 0959-8049, 2017, Volume 77, pp. 57 - 74
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2014, Volume 70, Issue 2, pp. 223.e1 - 223.e17
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2010, Volume 64, Issue 2, pp. 352 - 404
Sézary syndrome (SS) has a poor prognosis and few guidelines for optimizing therapy. The US Cutaneous Lymphoma Consortium, to improve clinical care of patients... 
Dermatology | Sézary syndrome | PEGYLATED LIPOSOMAL DOXORUBICIN | PHASE-II TRIAL | LOW-DOSE METHOTREXATE | Sezary syndrome | COMBINED-MODALITY THERAPY | PURINE NUCLEOSIDE PHOSPHORYLASE | BONE-MARROW-TRANSPLANTATION | ELECTRON-BEAM THERAPY | CHRONIC LYMPHOCYTIC-LEUKEMIA | T-CELL LYMPHOMA | ADVANCED MYCOSIS-FUNGOIDES | DERMATOLOGY | Sezary Syndrome - immunology | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Skin Neoplasms - therapy | Humans | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Combined Modality Therapy | Methotrexate - therapeutic use | Evidence-Based Medicine | Alkylating Agents - therapeutic use | Mycosis Fungoides - pathology | Retinoids - therapeutic use | Mycosis Fungoides - therapy | Sezary Syndrome - therapy | Quality of Life | Histone Deacetylase Inhibitors - therapeutic use | Drug Therapy, Combination | Sezary Syndrome - pathology | Immunologic Factors - therapeutic use | Medical colleges | Care and treatment | Leukemia | Interferon alpha | Mycoses | Transplantation | Non-Hodgkin's lymphomas | Research | Biological response modifiers | T cells | Hematopoietic stem cells | Consortia | Alkaloids | Interleukins | Formulae, receipts, prescriptions | Physiological aspects | Methotrexate | Health aspects | Dendritic cells | Oncology, Experimental | Coumarins | Dermatologic agents | Transforming growth factors | Preventive health services | Monoclonal antibodies | Nucleosides | Medicine, Preventive | Interferon gamma | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2010, Volume 28, Issue 31, pp. 4730 - 4739
Journal Article